Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/12/2026 Issue ¦ QNB Finance Ltd - Series 426 USD 20,000,000 FRN due July 2027     ISIN Number ¦ XS2501754340 ISIN Reference ¦ 250175434 Issue Nomin USD ¦ 20000000 Period ¦ 10/20/2025 to 1/20/2026   Payment Date 1/20/2026 Number of Days ¦ 92 Rate ¦ 5.44619   Denomination USD ¦ 200000   ¦ 20000000   ¦       Amount Payable per Denomination ¦ 2783.61   ¦ 278360.82   ¦       Bank of New York     Rate F...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Franklin Templeton announced today that certain closed-end funds have declared distributions pursuant to their managed distribution policy for the next three months. Month Record Date Ex-Dividend Date Payable Date January 1/23/2026 1/23/2026 1/30/2026 February 2/20/2026 2/20/2026 2/27/2026 March 3/24/2026 3/24/2026 3/31/2026 Ticker Fund Name Month Amount   Change from Previous Distribution TEI Templeton Emerging Markets Income Fund January $0.0475   - Feb...

DUBLIN--(BUSINESS WIRE)--The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030" report has been added to ResearchAndMarkets.com's offering. This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healt...

DUBLIN--(BUSINESS WIRE)--The "Mastering DHF, DMR & DHR - Essential FDA Documentation for Medical Devices (February 3, 2026)" training has been added to ResearchAndMarkets.com's offering. Medical device manufacturing is not an easy process. If anything goes wrong, the entire batch of products is at stake. Is there any solution to it? DHF, DMR, and DHR are the three Ds of medical device that needs to be managed carefully. Even though these files serve different purposes, it is essential to un...

NEW YORK--(BUSINESS WIRE)--Ninth Wave Introduces Compass, an AI-Driven Onboarding Assistant that Radically Simplifies and Accelerates Open Finance Integration....

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/12/2026 Issue ¦ QNB Finance Ltd- Series 392 USD 25,000,000 FRN due January 2027     ISIN Number ¦ XS2433158677 ISIN Reference ¦ 243315867 Issue Nomin USD ¦ 25000000 Period ¦ 10/20/2025 to 1/20/2026   Payment Date 1/20/2026 Number of Days ¦ 92 Rate ¦ 4.93319   Denomination USD ¦ 200000   ¦ 25000000   ¦       Amount Payable per Denomination ¦ 2521.41   ¦ 315176.03   ¦       Bank of New York     Rate...

LYON, Francia--(BUSINESS WIRE)--Fabentech, empresa biofarmacéutica francesa especializada en medidas médicas en respuesta a amenazas biológicas, anunció hoy que ha recibido la autorización de comercialización para Ricimed®, un tratamiento para la intoxicación por ricina. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única versión del texto que tend...

LIONE, Francia--(BUSINESS WIRE)--Fabentech, azienda biofarmaceutica francese specializzata in contromisure mediche contro le minacce biologiche, ha annunciato oggi di aver ricevuto l'autorizzazione alla commercializzazione per Ricimed®, un trattamento contro l'avvelenamento da ricina. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua...

LYON, Frankreich--(BUSINESS WIRE)--Fabentech, ein französisches biopharmazeutisches Unternehmen, das sich auf medizinische Gegenmaßnahmen gegen biologische Bedrohungen spezialisiert hat, gibt heute bekannt, dass es die Marktzulassung für Ricimed® erhalten hat, ein Medikament zur Behandlung von Rizinvergiftungen. Ricimed®, ein Gegenmittel gegen eine der giftigsten natürlichen Substanzen der Welt Zusätzlich zur unterstützenden Behandlung und in schweren Fällen, die eine sofortige Verabreichung er...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/13/2026 Issue ¦ GE Capital European Funding - Series 4661 EUR 50,000,000 FRN Due 15 Oct 2032     ISIN Number ¦ XS0322844779 ISIN Reference ¦ 32284477 Issue Nomin EUR ¦ 50000000 Period ¦ 1/15/2026 to 4/15/2026   Payment Date 4/15/2026 Number of Days ¦ 90 Rate ¦ 2.566   Denomination EUR ¦ 50000   ¦ 50000000   ¦       Amount Payable per Denomination ¦ 320.75   ¦ 320750   ¦       Bank of New York    ...